Illumina Inc
NASDAQ:ILMN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
98.2977
155.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Illumina Inc
Wall Street
Price Targets
ILMN Price Targets Summary
Illumina Inc
According to Wall Street analysts, the average 1-year price target for
ILMN
is 166.04 USD
with a low forecast of 121.2 USD and a high forecast of 264.6 USD.
ILMN Last Price Targets
Illumina Inc
The latest public price target was made on Nov 6, 2024 by
Catherine Ramsey Schulte
from
Robert W. Baird
,
who expects
ILMN
stock to
rise by 3%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Catherine Ramsey Schulte
Robert W. Baird
|
139
USD
Upside 3% |
1 month ago
Nov 6, 2024
|
Illumina (ILMN) PT Raised to $139 at Baird
StreetInsider
|
Kyle Mikson
Canaccord Genuity
|
145
USD
Upside 7% |
1 month ago
Nov 5, 2024
|
Illumina (ILMN) PT Raised to $145 at Canaccord Genuity
StreetInsider
|
Luke Sergott
Barclays
|
145
USD
Upside 7% |
1 month ago
Nov 5, 2024
|
Illumina (ILMN) PT Raised to $145 at Barclays
StreetInsider
|
Shubhangi Gupta
HSBC
|
180
USD
Upside 33% |
2 months ago
Oct 17, 2024
|
HSBC Upgrades Illumina (ILMN) to Buy
StreetInsider
|
Jasper Hellweg
Argus Research
|
150
USD
Upside 11% |
3 months ago
Aug 28, 2024
|
Argus Upgrades Illumina (ILMN) to Buy
StreetInsider
|
|
Narumi Nakagiri
Daiwa
|
154
USD
Upside 14% |
4 months ago
Aug 16, 2024
|
Daiwa Securities Upgrades Illumina (ILMN) to Buy (1)
StreetInsider
|
Sung Ji Nam
Scotiabank
|
164
USD
Upside 21% |
4 months ago
Aug 15, 2024
|
Illumina (ILMN) PT Lowered to $164 at Scotiabank
StreetInsider
|
|
Luke Sergott
Barclays
|
125
USD
Downside 7% |
4 months ago
Aug 14, 2024
|
This Starbucks Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Benzinga
|
Nick Setyan
Wedbush
|
58
USD
Downside 57% |
4 months ago
Aug 14, 2024
|
This Starbucks Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Benzinga
|
David Westenberg
Piper Sandler
|
195
USD
Upside 44% |
4 months ago
Aug 13, 2024
|
Illumina price target lowered to $195 from $200 at Piper Sandler
TheFly
|
|
Catherine Ramsey Schulte
Robert W. Baird
|
124
USD
Downside 8% |
4 months ago
Aug 7, 2024
|
Illumina price target raised to $124 from $119 at Baird
TheFly
|
|
Dave Westenberg
Piper Sandler
|
200
USD
Upside 48% |
4 months ago
Jul 30, 2024
|
Piper Sandler Reiterates Overweight Rating on Illumina (ILMN)
StreetInsider
|
|
Catherine Ramsey Schulte
Robert W. Baird
|
119
USD
Downside 12% |
5 months ago
Jun 25, 2024
|
Illumina (ILMN) PT Lowered to $119 at Baird
StreetInsider
|
Vijay Kumar
Evercore ISI
|
175
USD
Upside 30% |
6 months ago
Jun 11, 2024
|
Illumina (ILMN) PT Lowered to $175 at Evercore ISI
StreetInsider
|
Doug Schenkel
Wolfe Research
|
175
USD
Upside 30% |
6 months ago
Jun 6, 2024
|
Wolfe Research Reiterates Outperform Rating on Illumina (ILMN)
StreetInsider
|
|
Kyle Mikson
Canaccord Genuity
|
130
USD
Downside 4% |
6 months ago
Jun 4, 2024
|
Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN) on latest GRAIL Updates
StreetInsider
|
Tycho Peterson
Jefferies
|
115
USD
Downside 15% |
6 months ago
Jun 3, 2024
|
Jefferies Starts Illumina (ILMN) at Hold
StreetInsider
|
|
Vijay Kumar
Evercore ISI
|
200
USD
Upside 48% |
8 months ago
Apr 12, 2024
|
Illumina $1B cash outlay for Grail divestment 'better than fears,' says Evercore
TheFly
|
Daniel Arias
Stifel Nicolaus
|
225
USD
Upside 67% |
1 year ago
Aug 10, 2023
|
Illumina To Bear The Brunt Of Slowdown In Consumables Purchasing Amid Lower Demand In China: Analyst
Benzinga
|
|
Unknown Analyst
Leerink Partners
|
250
USD
Upside 85% |
1 year ago
Feb 8, 2023
|
SVB Leerink Maintains Outperform on Illumina, Raises Price Target to $250
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ILMN's stock price target?
Price Target
166.04
USD
According to Wall Street analysts, the average 1-year price target for
ILMN
is 166.04 USD
with a low forecast of 121.2 USD and a high forecast of 264.6 USD.
What is Illumina Inc's Revenue forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
Illumina Inc's revenue is
9%.
The projected
CAGR
for the next 4 years is
4%.
You don't have any saved screeners yet
